Skip to content
Wednesday, November 18, 2026
AtlasLine Blog

Zimbabwe Declines ‘One-Sided’ US Health Aid Package Over Data Fears

Health funding illustration
The offered American financial assistance was aimed at programmes for treating and preventing HIV/Aids, TB, and malarial diseases.

Zimbabwe has rejected a significant American healthcare agreement valued at 367 million US dollars (£272m) spanning five years due to the United States' request for confidential data.

The decision came to light following a official document dated December was leaked, indicating that Head of State Emmerson Mnangagwa felt the deal was "lopsided".

A government spokesperson later clarified that the United States was demanding access to health data for scientific study and profit but was unwilling to guarantee the benefits from any future vaccines.

"We will now turn to the challenging and unfortunate process of winding down our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy said the United States had furnished more than $1.9bn in health funding to Zimbabwe over the last two decades.

A physicians' group in Zimbabwe has appealed for further negotiations to find a deal agreeable to both sides so the nation's vital HIV treatment initiative can be sustained.

Wider Background

Zimbabwe's decision comes after a similar situation in Kenya, where a court suspended a related deal with the US after legal challenges were raised about the security of citizens' medical information.

After resuming the presidency recently, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).

The agency had overseen assistance for the US government, but Trump claimed its spending was "inefficient" and his government was pursuing direct bilateral deals to boost openness and accountability.

According to reports, 16 nations in Africa have to date agreed to similar health pacts, representing more than $18.3bn in committed funds.

Details of the Declined Deal

The money for Zimbabwe would have funded "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"We believe this collaboration might have yielded immense benefits for the people of Zimbabwe, especially the 1.2 million currently receiving HIV treatment through US-supported initiatives," the Ambassador commented.

However, government spokesperson Nick Mangwana argued the arrangement was "unfair".

"The proposal required Zimbabwe to share its biological resources and data for a long time, without any corresponding promise of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that might be developed from that shared data," he stated.

"Effectively, our nation would supply the basic resources for scientific discovery without any assurance that the resulting innovations would be accessible to our citizens if a new disease outbreak arise."

Sovereignty and International Frameworks

He also pointed out that the American exit from the World Health Organization (WHO) and its push of one-on-one deals were undermining structures already established through the international organization.

Mangwana gave as an example its Pathogen Access and Benefit Sharing system created to manage future pandemics.

"This mechanism is designed to guarantee that when a country provides its data, the benefits – such as vaccines and treatments – are shared equitably, not commercialised exclusively by those with the capability to create them."

Zimbabwe's reservations over the US deal "must not be interpreted as opposition to America," Mangwana stressed.

"We encourage continued dialogue with our US partners on how future collaboration might be structured in a way that honours the independence and interests of each country."

Health Experts Reaction

A leading public health body stated it acknowledged the government's concerns, but urged that talks must proceed given that much of the nation's Aids initiatives relied on external financing.

"In cases where specific concerns arise, including those relating to information security or implementation frameworks, these can often be addressed through detailed discussion and negotiated safeguards," the group added.

This impasse underscores the ongoing debate between receiving vital international aid and safeguarding a country's data in an ever more interconnected world.

LJ
The writer

Lisa Jones

A seasoned travel writer and cultural enthusiast with over a decade of experience exploring global destinations and sharing unique stories.

AtlasLine Blog

Type to search articles.